|Articles|April 1, 2004

Mohs first line of therapy for non-melanoma eyelid tumors

Wailea, Hawaii - After reviewing more than 100 previous studies regarding different modalities for treating non-melanoma eyelid tumors, the evidence-based results clearly point to Mohs micrographic surgery as the formidable first line of therapy, according to Harry H. Sharata, M.D., Ph.D.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME